|
|
| |
|
|
| 本文已被：浏览 1130次 下载 649次 |
码上扫一扫！ |
|
|
| 针刺人迎穴调控RhoA/ROCK1通路改善自发性高血压大鼠血压及血管损伤的机制研究 |
|
周诗远1,2, 杨永可3, 熊飞然4, 陆妍5, 赵轶文6, 刘嘉妍7, 史慧妍1,2, 石学敏1,2
|
|
1.天津中医药大学第一附属医院针灸科, 天津 300193;2.国家中医针灸临床医学研究中心, 天津 300193;3.宁波市北仑区人民医院康复科, 宁波 315800;4.河北省三河市中医院中医科, 廊坊 065200;5.天津市北辰区双环邨街社区卫生服务中心中医科, 天津 300134;6.天津中医药大学, 天津 300193;7.天津市西青区中北镇社区卫生服务中心针灸科, 天津 300111
|
|
| 摘要: |
| [目的]基于RhoA/ROCK1通路探讨针刺人迎穴对自发性高血压大鼠血压及血管损伤的作用机制。[方法] 11周龄雄性自发性高血压大鼠,随机分为模型组、针刺组和西药组,选取同周龄雄性Wistar大鼠作为正常组。针刺组和西药组分别给予针刺人迎穴和厄贝沙坦灌胃给药。观察大鼠血压变化情况,酶联免疫吸附实验(ELISA)检测血管紧张素Ⅱ(AngⅡ)和ROCK1的表达水平,逆转录聚合酶链反应(RT-PCR),蛋白免疫印迹法(Western Blot)检测内皮素-1(ET-1)和人血小板衍化生长因子-AA(PDGF-AA)的mRNA和蛋白表达水平,免疫荧光检测颈动脉组织中基质金属蛋白酶2(MMP2)和RhoA的定位及表达水平。[结果] 1)与模型组比较,西药组和针刺组在治疗3周,治疗6周时的平均动脉压有降低(P＜0.05)。2)与模型组比较,西药组和针刺组在治疗6周时ET-1和PDGF-AA的mRNA和蛋白的表达均降低(P＜0.05)。3)与模型组比较,西药组和针刺组在治疗6周时RhoA、AngⅡ和ROCK1的蛋白表达均降低(P＜0.05),针刺组在治疗6周时MMP2的蛋白表达降低(P＜0.05)。4)与西药组比较,针刺组在治疗6周时AngⅡ和ROCK1的蛋白表达均降低(P＜0.05)。[结论]针刺人迎穴可能通过下调颈动脉RhoA/ROCK1通路来改善自发性高血压大鼠血压及血管损伤。 |
| 关键词: 人迎穴 针刺 血压 ET-1 AngⅡ PDGF-AA MMP2 RhoA/ROCK1通路 |
| DOI：10.11656/j.issn.1672-1519.2024.01.14 |
| 分类号:R544 |
| 基金项目:国家自然科学基金青年项目(81503635)。 |
|
| Study on the mechanism of regulating RhoA/ROCK1 pathway by acupuncture at Renying Point to improve blood pressure and vascular injury in spontaneously hypertensive rats |
|
ZHOU Shiyuan1,2, YANG Yongke3, XIONG Feiran4, LU Yan5, ZHAO Yiwen6, LIU Jiayan7, SHI Huiyan1,2, SHI Xuemin1,2
|
|
1.Department of Acupuncture, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;2.National Clinical Research Center of Chinese Medicine Acupuncture and Moxibustion, Tianjin 300193, China;3.Department of Psychiatry, Ningbo Beilun District People's Hospital, Ningbo 315800, China;4.Department of Traditional Chinese Medicine, Hebei Sanhe Traditional Chinese Medicine Hospital, Langfang 065200, China;5.Department of Traditional Chinese Medicine, Beichen District Shuanghuantun Street Community Health Service Center, Tianjin 300134, China;6.Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China;7.Department of Acupuncture, Xiqing District Zhongbei Community Health Service Center, Tianjin 300111, China
|
| Abstract: |
| [Objective] To explore the effect and mechanism of acupuncture at Renying Point on blood pressure and vascular injury in spontaneously hypertensive rats(SHR) by regulating RhoA/ROCK1 signaling pathway. [Methods] The 11 week-old male spontaneously hypertensive rats(SHR) and Wistar rats were randomly divided into four groups:SHR group,acupuncture group,medicine group and Wistar group. The medicine group was given the irbesartan by gavage,the acupuncture group was treated with acupuncture on the acupoints of Renying(ST-9). Observe the changes in blood pressure,detect the expression levels of Ang Ⅱ and ROCK1 using ELISA,detect the mRNA and protein expression levels of ET-1 and PDGF-AA using RT-PCR and Western Blot,and detect the localization and expression levels of MMP2 and RhoA in carotid artery tissue using immunofluorescence. [Results] 1)Compared with the model group,the mean arterial pressure of the medicine group and the acupuncture group at 3 weeks and 6 weeks of treatment was significantly reduced.(P＜0.05). 2)Compared with model group,mRNA and protein expressions of ET-1 and PDGF-AA in Western medicine group and acupuncture group were significantly reduced after 6 weeks of treatment(P＜0.05). 3)Compared with model group,the protein expressions of RhoA,AngⅡ and ROCK1 in western medicine group and acupuncture group were significantly reduced after 6 weeks of treatment(P＜0.05),and the protein expression of MMP2 in acupuncture group was significantly reduced after 6 weeks of treatment(P＜0.05).4)Compared with Western medicine group,the protein expressions of Ang Ⅱ and ROCK1 in acupuncture group were significantly reduced after 6 weeks of treatment(P＜0.05). [Conclusion] Acupuncture at Renying Point can improve blood pressure and vascular injury in spontaneously hypertensive rats by down-regulating RhoA/ROCK1 pathway. |
| Key words: Renying Point acupuncture blood pressure ET-1 Ang Ⅱ PDGF-AA MMP2 RhoA/ROCK1 pathway |
|
|
|
|
